MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q3
hinzugefügt 19.11.2025
OpGen Langfristiger Schuldenstrom 2011-2025 | OPGN
Langfristiger Schuldenstrom Jährlich OpGen
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 174 K | 148 K | 378 K | 460 K | 964 K | 1.02 M | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.02 M | 148 K | 523 K |
Langfristiger Schuldenstrom anderer Aktien in der Diagnostik & Forschung
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
17.2 M | - | -17.87 % | $ 25.9 M |  Canada |
|
Centogene N.V.
CNTG
|
2.18 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Brainsway Ltd.
BWAY
|
824 K | $ 19.29 | -1.73 % | $ 99.4 M |  Israel |
 |
Accelerate Diagnostics
AXDX
|
829 K | - | -61.36 % | $ 2.46 M |  USA |
 |
Biocept
BIOC
|
518 K | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
915 K | - | 0.22 % | $ 16.8 M | USA |
 |
BioNano Genomics
BNGO
|
2.99 M | $ 1.52 | -0.65 % | $ 1.93 M | USA |
 |
Castle Biosciences
CSTL
|
1.66 M | $ 40.09 | -0.27 % | $ 1.11 B | USA |
 |
Danaher Corporation
DHR
|
173 M | $ 231.47 | 0.28 % | $ 169 B | USA |
 |
DarioHealth Corp.
DRIO
|
111 K | $ 10.04 | -0.99 % | $ 285 M | Israel |
 |
DexCom
DXCM
|
21.1 M | $ 67.42 | 0.84 % | $ 26 B | USA |
 |
Enzo Biochem
ENZ
|
841 K | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
27.4 M | $ 101.54 | -0.05 % | $ 18.8 B | USA |
 |
Fulgent Genetics
FLGT
|
1.44 M | $ 27.01 | -0.55 % | $ 817 M | USA |
 |
Global Cord Blood Corporation
CO
|
147 K | - | - | $ 399 M |  China |
 |
Genetic Technologies Limited
GENE
|
264 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
21.5 M | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
3.07 M | - | -11.32 % | $ 2.94 M | USA |
 |
CareDx, Inc
CDNA
|
5.94 M | $ 19.73 | -1.45 % | $ 1.06 B | USA |
 |
Celcuity
CELC
|
172 K | $ 102.61 | 0.25 % | $ 4.05 B | USA |
 |
Anixa Biosciences
ANIX
|
29 K | $ 3.42 | 3.64 % | $ 109 K | USA |
 |
Co-Diagnostics
CODX
|
838 K | $ 0.24 | -1.79 % | $ 7.04 M | USA |
 |
Heska Corporation
HSKA
|
2.94 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
475 K | - | -20.0 % | $ 1.06 M | USA |
 |
IQVIA Holdings
IQV
|
99 M | $ 226.02 | 0.39 % | $ 41 B | USA |
 |
Guardant Health
GH
|
29.2 M | $ 102.38 | -0.12 % | $ 12.6 B | USA |
 |
Aspira Women's Health
AWH
|
77 K | - | -6.19 % | $ 10.5 M | USA |
 |
Illumina
ILMN
|
79 M | $ 135.32 | -0.64 % | $ 21.5 B | USA |
 |
Charles River Laboratories International
CRL
|
54.2 M | $ 203.16 | 0.14 % | $ 10.4 B | USA |
 |
ENDRA Life Sciences
NDRA
|
96.9 K | $ 5.1 | - | $ 2.74 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
241 M | $ 26.98 | 0.37 % | $ 20 B |  Niderland |
 |
Quest Diagnostics Incorporated
DGX
|
173 M | $ 175.92 | 0.48 % | $ 19.5 B | USA |
|
Biodesix
BDSX
|
719 K | $ 6.82 | 1.04 % | $ 884 M | USA |
 |
Motus GI Holdings
MOTS
|
169 K | - | -34.28 % | $ 263 K | Israel |
 |
Laboratory Corporation of America Holdings
LH
|
185 M | $ 254.46 | 0.52 % | $ 21.3 B | USA |
 |
ICON Public Limited Company
ICLR
|
24.3 M | $ 183.68 | 0.33 % | $ 15.2 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
21.5 M | $ 688.18 | 0.86 % | $ 56.8 B | USA |
 |
Lantheus Holdings
LNTH
|
1.87 M | $ 66.68 | 0.23 % | $ 4.61 B | USA |
 |
Mettler-Toledo International
MTD
|
29.8 M | $ 1 417.16 | 0.18 % | $ 30.1 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
12.8 M | $ 6.55 | -0.15 % | $ 593 M | USA |
 |
QIAGEN N.V.
QGEN
|
23.4 M | $ 45.48 | -0.29 % | $ 10.1 B | Niderland |
 |
Biomerica
BMRA
|
358 K | $ 2.65 | 1.15 % | $ 6.09 M | USA |
 |
Bioventus
BVS
|
4.06 M | $ 7.38 | -1.99 % | $ 462 M | USA |
 |
NeoGenomics
NEO
|
3.38 M | $ 12.3 | -0.97 % | $ 1.56 B | USA |